Pancreatic polypeptide is increased in patients with advanced malignant disease

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2515-2517

  Hjalmarsen, Audhild ^a   Bremnes, Roy M ^a   Aasebø, Ulf ^a   Jorde, Rolf ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Cardiovascular tests; Malignant disease; Pancreatic polypeptide

Indexed keywords

BIOCHEMICAL MARKER; PANCREAS POLYPEPTIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; BREATHING; CANCER PATIENT; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAND GRIP; HEART RATE; HORMONE RELEASE; HUMAN; LUNG CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; STANDING; VALSALVA MANEUVER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC POLYPEPTIDE; TUMOR MARKERS, BIOLOGICAL; VAGUS NERVE;

EID: 4444240261     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schwarts T W: Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85: 1411-25, 1983.
2. Rasmussen M H, Carstensen H, List S, Schwarts TW and Hilsted J: Impaired pancreatic polypeptide response to a meal in type I diabetic patients: Vagal neuropathy or islet cell dysfunction? Acta Endocrinologica 128: 221-4, 1993.
3. Hjalmarsen A, Aasebø U, Aleksandersen G and Jorde R: Cardiovascular responses to tests for autonomic dysfunction in patients with chronic obstructive pulmonary disease with and without continuous long-term oxygen therapy, J Autonom Nerv Syst 60: 169-74, 1996.
4. Omdal R, Jorde R, Mellgren S L and Husby G: Autonomic function in systemic lupus erythematosus. Lupus 3: 413-17, 1994.
5. Bordi C, Azzoni C, D'Adda T and Pizzi S: Pancreatic polypeptide-related tumors. Peptides 23: 339-48, 2002.
6. Schwartz TW: Pancreatic-polypeptide (PP) and endocrine tumors of the pancreas. Scand J Gastroent 14 Suppl 53: 93-100, 1979.
7. Clarke BF and Ewing DJ: Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15: 885-89, 1986.
8. Fuqua M, Peter M and Pfeifer MA: Clinical manifestations and tests for cardiovascular autonomic neuropathy. Clin Diabetes 10-12, 1988.
9. McLeod JG and Tuck RR: Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features. Ann Neurol 21: 419-30, 1987.
10. McLeod JG and Tuck RR: Disorders of the autonomic nervous system: Part 2. Investigation and treatment. Ann Neurol 21: 519-29, 1987.
11. Borst C, van Brederode JFM, Dunning AJ, de Rijk LG and Wieling W: Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 22: 163-66, 1982.
12. World Health Organization: Handbook for Reporting Results of Cancer Treatment. WHO offset publication no. 48. Geneva: WHO, 1979.
13. Jorde R and Burhol PG: Effects of jejunoileal bypass operation and Billroth II resection on postprandial plasma pancreatic polypeptide release. Scand J Gastroenterol 17: 613-17, 1982.
14. Benn J, Dyrberg T, Hilsted J, Nerup J and Sandahl Christiansen J: Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20: 190-94, 1981.
15. Stewart AG, Waterhouse JC and Howard P: Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 4: 1207-14, 1991.
16. Kaufmann H: The most common dysautonomias. Rev Neurol (1-15)36: 96-96, 2003.